ArticleMethods in molecular biology (Clifton, N.J.)2022
Individual Patient Data Meta-Analysis and Network Meta-Analysis.
Article in Methods in molecular biology (Clifton, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Optimizing Treatment Decision Estimation for Right-Censored Survival Data Through Parameter Transfer Learning.Statistics in medicine · 2026Article
- NMAsurv: An R Shiny application for network meta-analysis based on survival data.Research synthesis methods · 2025Review
- Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis.European heart journal · 2024Article
- Is Network Meta-analysis a Revolutionary Statistical Tool for Improving the Reliability of Clinical Trial Results? A Brief Overview and Emerging Issues Arising.In vivo (Athens, Greece)Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Meta-analyses are often conducted using trial-level summary data. However, when individual patient data (IPD ) is available, there is greater flexibility in the analysis and a wider range of statistical models that can be fitted. There are two approaches to fitting IPD models. The traditional two-stage approach involves analyzing each trial individually in the first stage and then combining trial estimates of treatment effectiveness in the second stage using methods developed for aggregate data meta-analysis. Growing in popularity is the one-stage approach in which trials are analyzed and synthesized within one statistical model whilst the clustering of patients within trials is accounted for. This chapter outlines both fixed effect and random effects one- and two-stage meta-analysis models for continuous, binary, and time-to-event outcomes. The meta-analysis framework is then extended to the scenario where there are more than two treatments and network meta-analysis models are described.The availability of IPD provides greater statistical power for investigating interactions between treatments and covariates. Treatment-covariate interactions contain both within- and across-trial information where the across-trial information may be subject to ecological bias. This chapter presents network meta-analysis models separating out the within- and across-trial information and finishes by considering practical solutions for dealing with missing covariate data, assessing the consistency assumption, combining IPD and aggregate data and specific considerations for time-to-event outcomes.
Indexed as
Identifiers
34550597What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.